Skip to main content
. 2023 Feb 28;14:1122. doi: 10.1038/s41467-023-36769-6

Fig. 1. Series description and study workflow.

Fig. 1

a Characteristics of the CNIO cohort used for WES and RNA-Seq analysis. Characteristics shown are: platform available (WES and RNA-Seq), preservation of material (FFPE or frozen), tumor type (non-metastatic, aggressive, metastatic, relapse or metastases), primary tumor and metastasis location, sex, age at diagnosis, genomic subtype and genotype. NA: information not available. b General overview of the study. See also Supplementary Table 1 and Supplementary Fig. 1.